Fomg Wound Care | |
2815 W Elk Ave, Duncan, OK 73533-1517 | |
(580) 252-3400 | |
(405) 779-2310 |
Full Name | Fomg Wound Care |
---|---|
Type | Facility |
Speciality | Clinic/center |
Location | 2815 W Elk Ave, Duncan, Oklahoma |
Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1073032660 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
213E00000X | Podiatrist | 239 (Oklahoma) | Secondary |
261Q00000X | Clinic/center | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Fomg Wound Care 2100 W Iowa Ave, Chickasha, OK 73018-2736 Ph: (405) 224-2100 | Fomg Wound Care 2815 W Elk Ave, Duncan, OK 73533-1517 Ph: (580) 252-3400 |
News Archive
Elderly people with the metabolic syndrome-defined as having multiple risk factors associated with developing diabetes and heart disease-had an increased risk of chronic kidney disease, according to a recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism.
Researchers at the University of Virginia School of Medicine have shed light on how cancers hijack the body's natural wound-healing response to grow and spread.
Ipsen today announced the initiation of an international, multi-center, controlled, randomized Phase II clinical trial to evaluate the safety and efficacy of BN83495, its investigational first-in-class steroid sulfatase (STS) inhibitor, in advanced endometrial cancer.
A key mechanism that appears to contribute to blood vessel damage in people with diabetes has been identified by researchers at Washington University School of Medicine in St. Louis.
› Verified 3 days ago